Evidence map›Paper›PMID 29728764›Full record

ArticleWorld journal of urology2018

The AdVance and AdVanceXP male sling in urinary incontinence: is there a difference?

Tanja Hüsch, Alexander Kretschmer, Frauke Thomsen, Dominik Kronlachner, Martin Kurosch, Alice Obaje, Ralf Anding, Ruth Kirschner-Hermanns, Tobias Pottek, Achim Rose and 17 more

Abstract readComparative StudyMulticenter Study
PubMed Publisher
In one paragraph

Article in World journal of urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Frontiers in surgery · 2019
    Article
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 20 institutions in 3 countries.

Tanja HüschDepartment of Urology and Pediatric Urology, University Medical Center of Johannes Gutenberg University, Mainz, Germany. tanja.huesch@uni-mainz.de.ORCID http://orcid.org/0000-0002-7872-5496
Alexander KretschmerDepartment of Urology, Ludwig-Maximilians-University, Campus Großhadern, Munich, Germany.
Frauke ThomsenDepartment of Urology and Pediatric Urology, University Hospital Frankfurt, Frankfurt, Germany.
Dominik KronlachnerDepartment of Urology and Pediatric Urology, University Hospital Frankfurt, Frankfurt, Germany.
Martin KuroschDepartment of Urology and Pediatric Urology, University Medical Center of Johannes Gutenberg University, Mainz, Germany.
Alice ObajeDepartment of Urology, St. Bernward Hospital Hildesheim, Hildesheim, Germany.
Ralf AndingNeuro-Urology, Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.
Ruth Kirschner-HermannsNeuro-Urology, Department of Urology and Pediatric Urology, University Hospital Bonn, Bonn, Germany.
Tobias PottekDepartment of Urology, Vivantes Klinikum Am Urban, Reconstructive Urology, Berlin/Asklepios Hospital West Hamburg, Hamburg, Germany.
Achim RoseDepartment of Urology and Pediatric Urology, Helios Hospital Duisburg, Duisburg, Germany.
Roberto OlianasDepartment of Urology, Hospital Lüneburg, Lüneburg, Germany.
Lukas LusuardiDepartment of Urology, Landeskrankenhaus Salzburg, Paracelsus Medical University, Salzburg, Austria.
Alexander FriedlDepartment of Urology, Barmherzige Schwestern Krankenhaus, Vienna, Austria.
Roland HombergDepartment of Urology and Pediatric Urology, St. Barbara Hospital Hamm GmbH, Hamm, Germany.
Jesco PfitzenmaierDepartment of Urology, Evangelic Hospital Bethel, Bielefeld, Germany.
Fabian QueissertDepartment of Urology, University Hospital Muenster, Muenster, Germany.
Carsten M NaumannDepartment of Urology and Pediatric Urology, University Hospital Schleswig Holstein Campus Kiel, Kiel, Germany.
Josef SchweigerDepartment of Urology and Pediatric Urology, Catholic Hospital St. Johann Nepomuk, Erfurt, Germany.
Carola WotzkaDepartment of Urology, Diakonie Hospital Stuttgart, Stuttgart, Germany.
Joanne Nyarangi-DixDepartment of Urology and Pediatric Urology, University Hospital Heidelberg, Heidelberg, Germany.
Bernhard BrehmerDepartment of Urology, Diakonie Hospital Schwäbisch Hall, Schwäbisch Hall, Germany.
Rudi AbdunnurDepartment of Urology and Pediatric Urology, Helios Hospital Schwelm, Schwelm, Germany.
Hagen LoertzerDepartment of Urology and Pediatric Urology, Westpfalz Hospital, Kaiserslautern, Germany.
Kurt UlmInstitute of Medical Informatic, Statistic and Epidemiology, Technical University Munich, Munich, Germany.
Wilhelm HübnerDepartment of Urology, Hospital Weinviertel Korneuburg, Korneuburg, Austria.
Ricarda M BauerDepartment of Urology, Ludwig-Maximilians-University, Campus Großhadern, Munich, Germany.
Axel HaferkampDepartment of Urology and Pediatric Urology, University Medical Center of Johannes Gutenberg University, Mainz, Germany.
Johannes Gutenberg University Mainz · DEGoethe University Frankfurt · DEUniversity Hospital Bonn · DEBarmherzige Schwestern Krankenhaus Wien · ATDiakonie-Klinikum Stuttgart · DEEvangelisches Diakoniekrankenhaus · DEEvangelisches Krankenhaus Bielefeld · DEHeidelberg University · DEHelios Hospital Schwerin · DEKatholisches Krankenhaus St. Johann Nepomuk · DEKlinikum Lüneburg · DELandesklinikum Korneuburg · ATLudwig-Maximilians-Universität München · DEParacelsus Medical University · ATSt. Bernward Krankenhaus · DEUniversity Hospital Münster · DEUniversity Hospital Schleswig-Holstein · DEUniversity of British Columbia · CAVivantes Klinikum · DEWestpfalz Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare the efficacy and perioperative complications of the AdVanceXP with the original AdVance male sling.

methodsWe retrospectively enrolled 109 patients with an AdVance and 185 patients with an AdVanceXP male sling. The baseline characteristics and complication rates were analyzed retrospectively. Functional outcome and quality of life were evaluated prospectively by standardized, validated questionnaires. The Chi

resultsRegarding operation time, there was no significant difference between the slings (p = 0.146). The complication rates were comparable in both groups except for postoperative urinary retention. This occurred significantly more often in patients with the AdVanceXP (p = 0.042). During follow-up, no differences could be identified regarding ICIQ-SF, PGI or I-QoL or number of pad usage.

conclusionsThe AdVance and AdVanceXP are safe and effective treatment options for male stress urinary incontinence. However, the innovations of the AdVanceXP sling did not demonstrate a superiority over the original AdVance sling regarding functional outcome.

Indexed as

Suburethral SlingsAgedChi-Square DistributionFollow-Up StudiesHumansMaleOperative TimeProspective StudiesQuality of LifeRetrospective StudiesTreatment OutcomeUrinary Incontinence, StressAdVanceAdVanceXPMaleMale slingStress urinary incontinence

Identifiers

PMID29728764
OpenAlexW2802480707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.